01463nas a2200325 4500000000100000008004100001260001200042653002900054653003000083653001200113653001900125653002200144653001800166653001500184653001300199100001400212700001400226700001600240700001400256700001300270700001200283700001400295700001200309245016100321856012600482300001200608490000600620520049700626022001401123 2020 d c01/202010aErythema multiforme like10aerythema nodosum leprosum10aleprosy10amultibacillary10amultidrug therapy10areal-time PCR10aresistance10asteroids1 aSardana K1 aKulhari A1 aMathachan S1 aKhurana A1 aBansal P1 aAhuja A1 aLavania M1 aAhuja M00aLate leprosy reaction presenting as erythema multiforme-like erythema nodosum leprosum with underlying rifampicin resistance and its potential implications. uhttp://www.ijmyco.org/downloadpdf.asp?issn=2212-5531;year=2020;volume=9;issue=2;spage=226;epage=228;aulast=Sardana;type=2 a226-2280 v93 a

Erythema multiforme (EM)-like erythema nodosum leprosum (ENL) is a rare atypical presentation, and its late appearance after the completion of multidrug therapy (MDT) is unusual. We describe the case of a lepromatous leprosy patient who after the completion of MDT presented to us with late EM-like ENL and was found to be resistant to rifampicin. We discuss the implications of this finding and the potential role of resistant bacilli in causing reactions with atypical presentations.

 a2212-554X